NCT00368108

Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 752 (actual)
• Sponsor: Eisai Inc. · Industry
• Sex: All
• Age: 30 Years
• Healthy volunteers: Not accepted

Summary

This is a multi-center, randomized, double-blind, placebo-controlled, parallel-group study of E2007 in levodopa treated Parkinson's disease patients with motor fluctuations.

Conditions

• Parkinson's Disease

Interventions

Type	Name	Description
DRUG	2 mg perampanel	2 mg perampanel
DRUG	4 mg perampanel	4 mg perampanel
DRUG	placebo comparator	placebo comparator

Timeline

• Start date: 2006-08-01
• Primary completion: 2008-01-01
• Completion: 2008-01-01
• First posted: 2006-08-24
• Last updated: 2013-05-20
• Results posted: 2013-02-05

Locations

114 sites across 2 countries: United States, Canada